Can Supplements Reduce Your Risk of Alzheimer Disease?
Supplements Studied to Stop or Slow the Progression of Alzheimer Disease
Other Essential Nutrients
Are Supplements Safe?
Are Supplements Worth it?
National Alzheimer’s Association http://www.alz.org
National Institute on Aging http://www.nia.nih.gov
Alzheimer Society of Canada http://www.alzheimer.ca
Health Canada http://www.hc-sc.gc.ca
Alternative treatments Alzheimer's Association website. Available at: http://www.alz.org/alzheimers%5Fdisease%5Falternative%5Ftreatments.asp#top. Accessed December 31, 2014.
Alzheimer disease. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated November 19, 2014. Accessed December 31, 2014.
Antioxidants and health: an introduction. National Center for Complementary and Alternative Medicine website. Available at: http://nccam.nih.gov/health/antioxidants/introduction.htm. Updated November 2013. Accessed December 31, 2014.
Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Milano). 1993;5:123-133.
Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002;287:3223-3229.
Haag M. Essential fatty acids and the brain. Can J Psychiatry. 2003;48:195-203.
Luchsinger JA, Tang M-X, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol. 2003;60:203-208.
Miller ER, Pastor-Barruso R, Dalal D, et al. Meta-analysis: high dose vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37-46.
Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002;287:3230-3237.
Morris MS. Homocysteine and Alzheimer’s disease. Lancet Neurol. 2003;2:425-428.
Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol. 1998;55:1409-1415.
Pettegrew JW, Klunk WE, Panchalingam K, Kanfer JN, McClure RJ. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging. 1995;16:1-4.
Solomon PR, Adams F, Silver A, Zimmer J, DeVeaux R. Ginkgo for memory enhancement: a randomized controlled trial. JAMA. 2002;288:835-840.
Spagnoli A, Lucca U, Menasce G, et al. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology. 1991;41:1726-1732.
Thal LJ, Carta A, Clarke WR, Ferris SH, Friedland RP, Petersen RC, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology. 1996;47:705-711.
Youdim KA, Martin A, Joseph JA. Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci. 2000;18:383-399.
- Reviewer: Michael Woods, MD
- Review Date: 12/2014 -
- Update Date: 12/31/2014 -
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
Copyright © EBSCO Publishing
All rights reserved.